Improved combined solid-phase extraction-RIA method for quantifying zalcitabine in plasma

Clinical Chemistry

Volumn 42, Issue 3, 1996, Pages 465-466

  Kastrissios, Helen ^a   Nakano, Masako ^a   Burton, Patricia ^a   Blaschke, Terrence ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZALCITABINE;

ACCURACY; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; RADIOIMMUNOASSAY; SOLID PHASE EXTRACTION; TECHNIQUE;

EID: 0029930004     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.3.465     Document Type: Article

References (5)

1. Kelley JA, Litterst CL, Roth JS, Vistica DT, Poplack DG, Cooney DA, et al. The disposition and metabolism of 2′,3′-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys. Drug Metab Dispos 1987;15:595-601.
2. Hawkins ME, Poplack DG, Pizzo PA, Balis FM. High-performance liquid chromatographic method for the analysis of 2′,3′-dideoxycytidine in human plasma [Letter]. J Chromatogr 1990;532:442-4.
3. Jajoo HK, Bennett SM, Kornhauser DM. Thermospray liquid chromatographic - mass spectrometric analysis of anti-AIDS nucleosides: quantification of 2′,3′-dideoxycytidine in plasma samples. J Chromatogr 1992;577:299-304.
4. Roberts WL, Buckley TJ, Rainey PM, Jatlow PI. Solid-phase extraction combined with radioimmunoassay for measurement of zalcitabine (2′,3′-dideoxycytidine) in plasma and serum. Clin Chem 1994;40:211-5.
5. Burger DM, Rosing H, Ten Napel CHH, Duyts T, Meenhorst PL, Mulder JW, et al. Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid. Antimicrob Agents Chemother 1994;38:2763-7.